Desenvolvimento de métodos de preparo de amostras para a determinação de impurezas elementares em medicamentos de uso oral

Detalhes bibliográficos
Autor(a) principal: Cauduro, Vitoria Hagemann
Data de Publicação: 2019
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/20854
Resumo: In this study, sample preparation methods were developed for the digestion of oral pharmaceutical drugs used in the treatment of type 2 diabetes, with the objective of quantifying elemental impurities from classes 1 (As, Cd, Hg and Pb) and 2A (Co, Ni and V) by inductively coupled plasma optical emission spectrometry (ICP-OES). For this, the microwave induced combustion (MIC), microwave-assisted wet digestion (MAWD) and microwave and ultraviolet-assisted wet digestion (MAWD-UV) methods were evaluated. Six pharmaceutical drugs from different classes, containing metformine hydrochloride (MET), glibenclamide (GLIB), pioglitazone hydrochloride (PIO), sitagliptin hydrochloride (SITA), canagliflozin (CANA) and repaglinide (REPA) were used for the development of the methods. The drugs MET and CANA were chosen for the optimization of the methods. For the MIC method, the reflux step (5 or 10 min), the absorbing solution (7 and 14.4 mol L-1 HNO3, mixtures of 14.4 mol L-1 HNO3, 12 mol L-1 HCl and H2O in the proportion of 1+1+1, and mixtures of 14.4 mol L-1 HNO3 and 12 mol L-1 HCl in the proportions of 1+1, 1+3 and 3+1), and the use of combustion aids (microcrystallin cellulose or NH4Cl) were evaluated. For the MAWD method, the irradiation time (45 or 55 min), the digestion solution (1, 2, 3, 7 or 14.4 mol L-1 HNO3), the addition of an auxiliary reagent (1 or 2 mL of 50% H2O2) and the use of simultaneous cooling during the digestion (60 m3 h-1 or 125 m3 h-1 air flow rate) were evaluated. As for the MAWD-UV method, the following conditions were used: 1 mol L-1 HNO3, irradiation program of 55 min with simultaneous cooling (air flow rate of 125 m3 h-1 ), with the auxiliary reagent being evaluated (1.6 or 3.2 mL of 50% H2O2). For all the procedures, both the carbon concentration and residual acidity were determined in the digests. The accuracy of the methods was evaluated based on analyte recovery after standard addition assays and, for the MAWD and MAWD-UV methods, by the digestion of certified reference materials (CRM). When using MIC, V recoveries were not possible for samples containing inorganic excipients. For the MAWD method, CANA digestion was possible using 3 mol L-1 HNO3, 1 mL of 50% H2O2 and a 55 min irradiation program. The digestion of the other samples was possible using 2 mol L-1 HNO3, 1 mL of 50% H2O2 and a 45 min irradiation program. By using MAWD-UV, it was possible to digest all samples using 1 mol L-1 HNO3, 1.6 mL of 50% H2O2 and a 55 min irradiation program. The resulting digests from the optimized methods contained low residual acidity and dissolved carbon, enabling the analytes’ determination free of interferences by ICP-OES. In this way, it was possible to develop efficient methods for the decomposition of oral pharmaceutical drugs and subsequent class 1 and 2A (ICH Q3D guidelines) elemental impurities determination.
id UFSM_7a2a1d59c1afcdba1adcefef1692bfb1
oai_identifier_str oai:repositorio.ufsm.br:1/20854
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Desenvolvimento de métodos de preparo de amostras para a determinação de impurezas elementares em medicamentos de uso oralDevelopment of sample preparation methods for elemental impurities determination in oral pharmaceutical drugsImpurezas elementaresMAWDMAWD-UVFármacosDiabetes tipo 2Elemental impuritiesPharmaceutical productsType 2 diabetesCNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICAIn this study, sample preparation methods were developed for the digestion of oral pharmaceutical drugs used in the treatment of type 2 diabetes, with the objective of quantifying elemental impurities from classes 1 (As, Cd, Hg and Pb) and 2A (Co, Ni and V) by inductively coupled plasma optical emission spectrometry (ICP-OES). For this, the microwave induced combustion (MIC), microwave-assisted wet digestion (MAWD) and microwave and ultraviolet-assisted wet digestion (MAWD-UV) methods were evaluated. Six pharmaceutical drugs from different classes, containing metformine hydrochloride (MET), glibenclamide (GLIB), pioglitazone hydrochloride (PIO), sitagliptin hydrochloride (SITA), canagliflozin (CANA) and repaglinide (REPA) were used for the development of the methods. The drugs MET and CANA were chosen for the optimization of the methods. For the MIC method, the reflux step (5 or 10 min), the absorbing solution (7 and 14.4 mol L-1 HNO3, mixtures of 14.4 mol L-1 HNO3, 12 mol L-1 HCl and H2O in the proportion of 1+1+1, and mixtures of 14.4 mol L-1 HNO3 and 12 mol L-1 HCl in the proportions of 1+1, 1+3 and 3+1), and the use of combustion aids (microcrystallin cellulose or NH4Cl) were evaluated. For the MAWD method, the irradiation time (45 or 55 min), the digestion solution (1, 2, 3, 7 or 14.4 mol L-1 HNO3), the addition of an auxiliary reagent (1 or 2 mL of 50% H2O2) and the use of simultaneous cooling during the digestion (60 m3 h-1 or 125 m3 h-1 air flow rate) were evaluated. As for the MAWD-UV method, the following conditions were used: 1 mol L-1 HNO3, irradiation program of 55 min with simultaneous cooling (air flow rate of 125 m3 h-1 ), with the auxiliary reagent being evaluated (1.6 or 3.2 mL of 50% H2O2). For all the procedures, both the carbon concentration and residual acidity were determined in the digests. The accuracy of the methods was evaluated based on analyte recovery after standard addition assays and, for the MAWD and MAWD-UV methods, by the digestion of certified reference materials (CRM). When using MIC, V recoveries were not possible for samples containing inorganic excipients. For the MAWD method, CANA digestion was possible using 3 mol L-1 HNO3, 1 mL of 50% H2O2 and a 55 min irradiation program. The digestion of the other samples was possible using 2 mol L-1 HNO3, 1 mL of 50% H2O2 and a 45 min irradiation program. By using MAWD-UV, it was possible to digest all samples using 1 mol L-1 HNO3, 1.6 mL of 50% H2O2 and a 55 min irradiation program. The resulting digests from the optimized methods contained low residual acidity and dissolved carbon, enabling the analytes’ determination free of interferences by ICP-OES. In this way, it was possible to develop efficient methods for the decomposition of oral pharmaceutical drugs and subsequent class 1 and 2A (ICH Q3D guidelines) elemental impurities determination.Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPqNeste trabalho, foram desenvolvidos métodos de decomposição de medicamentos de uso oral utilizados no tratamento da diabetes tipo 2, na sua forma comercial, visando à determinação de impurezas elementares das classes 1 (As, Cd, Hg e Pb) e 2A (Co, Ni e V) por espectrometria de emissão óptica com plasma indutivamente acoplado (ICP-OES). Foram avaliados os métodos de combustão iniciada por micro-ondas (MIC), decomposição por via úmida assistida por radiação micro-ondas (MAWD) e decomposição por via úmida assistida por radiação micro- ondas e ultravioleta (MAWD-UV). Seis amostras de medicamentos de classes diferentes, à base de cloridrato de metformina (MET), glibenclamida (GLIB), cloridrato de pioglitazona (PIO), fosfato de sitagliptina (SITA), canagliflozina (CANA) e repaglinida (REPA) foram utilizados no desenvolvimento desse trabalho. Os medicamentos MET e CANA foram escolhidos para as otimizações dos métodos. Para a MIC, foram avaliados o tempo de refluxo (5 ou 10 min), a solução absorvedora (HNO3 7 e 14,4 mol L-1, misturas de HNO3 14,4 mol L-1, HCl 12 mol L-1 e H2O na proporção de 1+1+1, e misturas de HNO3 14,4 mol L-1 e HCl 12 mol L-1 nas proporções de 1+1, 1+3 e 3+1), e auxiliares de combustão (celulose microcristalina ou NH4Cl). Para a MAWD, foram avaliados o tempo de irradiação (45 ou 55 min), a solução digestora (HNO3 1, 2, 3, 7 ou 14,4 mol L-1), o reagente auxiliar (1 ou 2 mL de H2O2 50%), e o uso de resfriamento simultâneo (vazão de ar de 60 m3 h-1 ou 125 m3 h-1). No caso da MAWD-UV, foram utilizados HNO3 1 mol L-1, tempo de irradiação de 55 min com resfriamento simultâneo (vazão de ar de 125 m3 h-1), sendo avaliada a concentração do reagente auxiliar (1,6 ou 3,2 mL de H2O2 50%). Para todos os procedimentos, foi feita a determinação da concentração de carbono dissolvido e acidez residual nos digeridos. A exatidão foi avaliada com base em ensaios de recuperação com adição de padrão e, para os métodos de MAWD e MAWD-UV, pela decomposição de materiais de referência certificados (CRMs). Utilizando a MIC, não foi possível obter recuperações quantitativas para V em nenhuma das condições avaliadas em amostras com excipientes inorgânicos. Para a MAWD, a decomposição da CANA foi possível usando HNO3 3 mol L-1, 1 mL de H2O2 50% e programa de irradiação de 55 min. Para as demais amostras, a decomposição foi possível usando HNO3 2 mol L-1, 1 mL de H2O2 50% e tempo de irradiação de 45 min. Usando a MAWD-UV, foi possível decompor todas as amostras usando HNO3 1 mol L-1, 1,6 mL de H2O2 50% e programa de irradiação de 55 min. Os digeridos dos métodos de decomposição otimizados apresentaram baixo teor de acidez residual e carbono dissolvido, possibilitando a determinação por ICP-OES livre de interferências. Desta forma, foi possível desenvolver métodos eficientes para a decomposição da matriz orgânica de medicamentos de uso oral e posterior determinação de impurezas elementares das classes 1 e 2A do Guia ICH Q3D.Universidade Federal de Santa MariaBrasilQuímicaUFSMPrograma de Pós-Graduação em QuímicaCentro de Ciências Naturais e ExatasFlores, Érico Marlon de Moraeshttp://lattes.cnpq.br/7167629055579212Costa, Adilson Ben daXXXXXXXXXXXXXXXMüller, Edson IrineuXXXXXXXXXXXXXXXXXXCauduro, Vitoria Hagemann2021-05-12T18:39:58Z2021-05-12T18:39:58Z2019-08-02info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/20854porAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2022-07-12T13:54:27Zoai:repositorio.ufsm.br:1/20854Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2022-07-12T13:54:27Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Desenvolvimento de métodos de preparo de amostras para a determinação de impurezas elementares em medicamentos de uso oral
Development of sample preparation methods for elemental impurities determination in oral pharmaceutical drugs
title Desenvolvimento de métodos de preparo de amostras para a determinação de impurezas elementares em medicamentos de uso oral
spellingShingle Desenvolvimento de métodos de preparo de amostras para a determinação de impurezas elementares em medicamentos de uso oral
Cauduro, Vitoria Hagemann
Impurezas elementares
MAWD
MAWD-UV
Fármacos
Diabetes tipo 2
Elemental impurities
Pharmaceutical products
Type 2 diabetes
CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA
title_short Desenvolvimento de métodos de preparo de amostras para a determinação de impurezas elementares em medicamentos de uso oral
title_full Desenvolvimento de métodos de preparo de amostras para a determinação de impurezas elementares em medicamentos de uso oral
title_fullStr Desenvolvimento de métodos de preparo de amostras para a determinação de impurezas elementares em medicamentos de uso oral
title_full_unstemmed Desenvolvimento de métodos de preparo de amostras para a determinação de impurezas elementares em medicamentos de uso oral
title_sort Desenvolvimento de métodos de preparo de amostras para a determinação de impurezas elementares em medicamentos de uso oral
author Cauduro, Vitoria Hagemann
author_facet Cauduro, Vitoria Hagemann
author_role author
dc.contributor.none.fl_str_mv Flores, Érico Marlon de Moraes
http://lattes.cnpq.br/7167629055579212
Costa, Adilson Ben da
XXXXXXXXXXXXXXX
Müller, Edson Irineu
XXXXXXXXXXXXXXXXXX
dc.contributor.author.fl_str_mv Cauduro, Vitoria Hagemann
dc.subject.por.fl_str_mv Impurezas elementares
MAWD
MAWD-UV
Fármacos
Diabetes tipo 2
Elemental impurities
Pharmaceutical products
Type 2 diabetes
CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA
topic Impurezas elementares
MAWD
MAWD-UV
Fármacos
Diabetes tipo 2
Elemental impurities
Pharmaceutical products
Type 2 diabetes
CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA
description In this study, sample preparation methods were developed for the digestion of oral pharmaceutical drugs used in the treatment of type 2 diabetes, with the objective of quantifying elemental impurities from classes 1 (As, Cd, Hg and Pb) and 2A (Co, Ni and V) by inductively coupled plasma optical emission spectrometry (ICP-OES). For this, the microwave induced combustion (MIC), microwave-assisted wet digestion (MAWD) and microwave and ultraviolet-assisted wet digestion (MAWD-UV) methods were evaluated. Six pharmaceutical drugs from different classes, containing metformine hydrochloride (MET), glibenclamide (GLIB), pioglitazone hydrochloride (PIO), sitagliptin hydrochloride (SITA), canagliflozin (CANA) and repaglinide (REPA) were used for the development of the methods. The drugs MET and CANA were chosen for the optimization of the methods. For the MIC method, the reflux step (5 or 10 min), the absorbing solution (7 and 14.4 mol L-1 HNO3, mixtures of 14.4 mol L-1 HNO3, 12 mol L-1 HCl and H2O in the proportion of 1+1+1, and mixtures of 14.4 mol L-1 HNO3 and 12 mol L-1 HCl in the proportions of 1+1, 1+3 and 3+1), and the use of combustion aids (microcrystallin cellulose or NH4Cl) were evaluated. For the MAWD method, the irradiation time (45 or 55 min), the digestion solution (1, 2, 3, 7 or 14.4 mol L-1 HNO3), the addition of an auxiliary reagent (1 or 2 mL of 50% H2O2) and the use of simultaneous cooling during the digestion (60 m3 h-1 or 125 m3 h-1 air flow rate) were evaluated. As for the MAWD-UV method, the following conditions were used: 1 mol L-1 HNO3, irradiation program of 55 min with simultaneous cooling (air flow rate of 125 m3 h-1 ), with the auxiliary reagent being evaluated (1.6 or 3.2 mL of 50% H2O2). For all the procedures, both the carbon concentration and residual acidity were determined in the digests. The accuracy of the methods was evaluated based on analyte recovery after standard addition assays and, for the MAWD and MAWD-UV methods, by the digestion of certified reference materials (CRM). When using MIC, V recoveries were not possible for samples containing inorganic excipients. For the MAWD method, CANA digestion was possible using 3 mol L-1 HNO3, 1 mL of 50% H2O2 and a 55 min irradiation program. The digestion of the other samples was possible using 2 mol L-1 HNO3, 1 mL of 50% H2O2 and a 45 min irradiation program. By using MAWD-UV, it was possible to digest all samples using 1 mol L-1 HNO3, 1.6 mL of 50% H2O2 and a 55 min irradiation program. The resulting digests from the optimized methods contained low residual acidity and dissolved carbon, enabling the analytes’ determination free of interferences by ICP-OES. In this way, it was possible to develop efficient methods for the decomposition of oral pharmaceutical drugs and subsequent class 1 and 2A (ICH Q3D guidelines) elemental impurities determination.
publishDate 2019
dc.date.none.fl_str_mv 2019-08-02
2021-05-12T18:39:58Z
2021-05-12T18:39:58Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/20854
url http://repositorio.ufsm.br/handle/1/20854
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Química
UFSM
Programa de Pós-Graduação em Química
Centro de Ciências Naturais e Exatas
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Química
UFSM
Programa de Pós-Graduação em Química
Centro de Ciências Naturais e Exatas
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1805922014494457856